Car T Cell Therapy Being Tested in Pancreatic CancerCuretoday.comA FLEDGLING BUT PROMISING form of immunotherapy known as CAR T cell therapy has been adapted to hit a new biologic target in the hopes that it will effectively fight advanced pancreatic c… Continue reading
Targeted Oncology |
Balar Discusses Current and Emerging Immunotherapy Treatments in Urothelial Carcinoma
Targeted Oncology In the current era, where we have single-agent immunotherapy as approved agents and it is essentially the defacto second-line agent of choice, patients who are PD-L1–negative may also potentially benefit. The real challenge is deciding ultimately if a … |
Wired.co.uk |
Ageing is a disease. Gene therapy could be the ‘cure’
Wired.co.uk She had spent more than two years studying literature, talking to experts, and had decided to undergo gene therapy – a treatment for genetic disorders that adds genes into cells to replace those that are faulty or absent. She ordered the therapeutic … |
|
Stem Cells Treat Baldness with PRP
KFSN-TV Kenneth Williams, D.O., a hair restoration surgeon at Orange County Hair Restoration in Irvine, California, may have new hope for Woelke and millions of others. He’s running a clinical trial that uses stem cells and platelet-rich plasma, or PRP, to … |
|
Anti-BCMA CAR T-Cell Therapy Approaches 80% Response Rate in Multiple Myeloma
Targeted Oncology An investigational anti–B-cell maturation antigen (BCMA) chimeric antigen receptor (CAR) T-cell therapy demonstrated an objective response rate (ORR) of 78% in patients with relapsed/refractory multiple myeloma, according to interim findings of a phase … |